LabCorp
LH
#1047
Rank
โ‚ฌ18.43 B
Marketcap
221,88ย โ‚ฌ
Share price
-1.18%
Change (1 day)
-0.90%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

P/E ratio for LabCorp (LH)

P/E ratio as of December 2025 (TTM): 25.3

According to LabCorp's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.2761. At the end of 2024 the company had a P/E ratio of 25.6.

P/E ratio history for LabCorp from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202425.6-45.96%
202347.3237.36%
202214.033.39%
202110.50.17%
202010.5-36.48%
201916.538.49%
201811.912.69%
201710.6-29.3%
201615.0-36.37%
201523.660.04%
201414.725.8%
201311.70.27%
201211.7

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Quest Diagnostics
DGX
21.2-16.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-13.5-153.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-3.33-113.17%๐Ÿ‡บ๐Ÿ‡ธ USA
IDEXX Laboratories
IDXX
56.1 121.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
25.2-0.40%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Translate Bio
TBIO.defunct
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.